Serum S100A12 as a Marker of Severity in Children with Community Acquired Pneumonia

Apr 19, 2026

0

Upload by Seraphina

Assesses serum S100A12 levels in children with community-acquired pneumonia and analyzes their association with disease severity and complications. A controlled cross-sectional study enrolls 90 children, including noncomplicated and complicated CAP groups and age- and sex-matched healthy controls, using British Thoracic Society severity grading to stratify pneumonia severity and evaluate clinical and laboratory correlations with host biomarkers.

Share with

Serum S100A12 as a Marker of Severity in Children with Community Acquired Pneumonia

Apr 19, 2026

0

Bookmark

Share

More Options

Fullscreen

This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.